Nanomedicine News

RSS
Fluorescent Nanoparticles of Specific Sizes Created to Study Tumour Drug Absorption

Fluorescent Nanoparticles of Specific Sizes Created to Study Tumour Drug Absorption

Celator Pharmaceuticals Extends Research Agreement with Cephalon

Celator Pharmaceuticals Extends Research Agreement with Cephalon

Tekmira Comments on Alnylam’s Recently Presented Clinical Data of ALN-VSP Candidate

Tekmira Comments on Alnylam’s Recently Presented Clinical Data of ALN-VSP Candidate

BIND Biosciences Begins Phase I Clinical Trial of Targeted Polymeric Nanoparticle

BIND Biosciences Begins Phase I Clinical Trial of Targeted Polymeric Nanoparticle

MIT Researchers Show Drugs Enclosed with Nanoparticles Treat Tumor Effectively

MIT Researchers Show Drugs Enclosed with Nanoparticles Treat Tumor Effectively

Scientists Create Nanoparticles That Mimic Few Properties of Red Blood Cells

Researcher Works to Identify Variety of Biomarkers for Early Cancer Detection

Researcher Works to Identify Variety of Biomarkers for Early Cancer Detection

Rensselaer Engineers Develop Nano-Based Liquid Pistons

Rensselaer Engineers Develop Nano-Based Liquid Pistons

Molecular Medicine Can Restore Lost Sight in Aged People

Iroko Pharma Reports Positive Trial Results of Nanotechnology Formulated Naproxen

Iroko Pharma Reports Positive Trial Results of Nanotechnology Formulated Naproxen

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.